Загрузка...
Potential Pitfalls of Crossover and Thoughts on Iniparib in Triple-Negative Breast Cancer
As recruitment for oncology clinical trials has become more difficult, there appears to have been an increase in the number of studies that allow patients in the control arm to “crossover” and receive the experimental therapy after disease progression. Although some researchers worry that allowing s...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3247787/ https://ncbi.nlm.nih.gov/pubmed/22045362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djr386 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|